Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Emergent Biosolutions, Inc. (NYSE: EBS).

Full DD Report for EBS

You must become a subscriber to view this report.


Recent News from (NYSE: EBS)

Altimmune: Suppressed, Immature, Or Dormant?
2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli...
Source: SeekingAlpha
Date: December, 05 2018 15:22
Detailed Research: Economic Perspectives on United Technologies, Walmart, Invitae, Emergent Biosolutions, U.S. Physical Therapy, and Amdocs - What Drives Growth in Today's Competitive Landscape
NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of United Technologies Corporation (NYSE:UTX), Walmart Inc. (NYSE:WMT), I...
Source: GlobeNewswire
Date: December, 04 2018 08:15
A Migrating Biotech Bear
Biotech Pulse Biotechnology is in a Bear Market. At least the midcap and smallcap segment of it. The S&P Biotechnology Select Index ( XBI ), which is weighted towards the midcap and smallcap companies, has dropped 24% from its high recorded on August 30 to its lowest point past Monda...
Source: SeekingAlpha
Date: November, 06 2018 08:39
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
GAITHERSBURG, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the fourth quarter and early portion of the first quart...
Source: GlobeNewswire
Date: November, 06 2018 07:00
JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action
Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov...
Source: SeekingAlpha
Date: November, 02 2018 07:59
Emergent BioSolutions Inc. (EBS) CEO Dan Abdun Nabi on Q3 2018 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS) Q3 2018 Results Conference Call November 01, 2018 05:00 PM ET Executives Bob Burrows - Vice President of Investor Relations Dan Abdun Nabi - Chief Executive Officer Bob Kramer - President and Chief Operating Officer Rich Lindahl - Chief Financia...
Source: SeekingAlpha
Date: November, 01 2018 22:20
Emergent BioSolutions misses by $0.03, misses on revenue
Emergent BioSolutions (NYSE: EBS ): Q3 Non-GAAP EPS of $0.55 misses by $0.03 ; GAAP EPS of $0.41 misses by $0.14 . More news on: Emergent BioSolutions Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 01 2018 16:39
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months of 2018
Q3 2018 performance in line with guidance Revises full year 2018 financial forecast to reflect anticipated strong full year organic business performance, expected at the higher end of the previous forecast, and impact of PaxVax and Adapt Pharma acquisitions GAITHERSBURG, Md., Nov. 01, ...
Source: GlobeNewswire
Date: November, 01 2018 16:30
Notable earnings after Thursday's close
AAPL , ACIA , ACLS , AIRG , AIV , ALEX , AMH , ANET , AOSL , APPN , ARCB , ATGE , ATHN , ATR , ATRC , ATSG , BCOV , BFAM , BIO , BL , BLDR , BNFT , BRKR , BVX , CARB , CATM , CBPO , CBS , CC , CCRN , CECO , CERS , CHEF , CNMD , CNXN , CORT , CPS , CPSI ...
Source: SeekingAlpha
Date: October, 31 2018 17:35
Factors of Influence in 2018, Key Indicators and Opportunity within StoneMor Partners, Catalyst Biosciences, Kennametal, Emergent Biosolutions, Kimball International, and Tailored Brands - New Research Emphasizes Economic Growth
NEW YORK, Oct. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of StoneMor Partners L.P. (NYSE:STON), Catalyst Biosciences, Inc. (NASDAQ:CB...
Source: GlobeNewswire
Date: October, 25 2018 07:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1460.4860.3261.3460.1155367,358
2017-03-2030.4830.3730.75830.04423,091
2017-03-1731.0030.4731.0030.02636,192
2017-03-1630.5030.8930.9130.19318,374
2017-03-1530.2630.5630.7130.07227,846

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-132,88512,94022.2952Cover
2018-12-124,0909,62442.4979Short
2018-12-112,12098,6822.1483Cover
2018-12-101,1886,50518.2629Cover
2018-12-071,25510,93311.4790Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EBS.


About Emergent Biosolutions, Inc. (NYSE: EBS)

Logo for Emergent Biosolutions, Inc. (NYSE: EBS)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $2,590,811,132 - 05/18/2018
  • Issue and Outstanding: 49,823,291 - 04/27/2018

 


Recent Filings from (NYSE: EBS)

Filing Type: CT ORDERFiling Source: edgar
Filing Date: September, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Automatic shelf registration statement of securities of well-known seasoned issuers
Filing Type: S-3ASRFiling Source: edgar
Filing Date: August, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 02 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: June, 12 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 24 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 04 2018

 

 


Daily Technical Chart for (NYSE: EBS)

Daily Technical Chart for (NYSE: EBS)


Stay tuned for daily updates and more on (NYSE: EBS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: EBS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EBS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EBS and does not buy, sell, or trade any shares of EBS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/